Membrane-based technologies for per- and poly-fluoroalkyl substances (PFASs) removal from water: Removal mechanisms, applications, challenges and perspectives.

Adsorption membrane Hybrid membrane processes Mechanisms Nanofiltration PFASs Reverse osmosis

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
12 2021
Historique:
received: 10 06 2021
revised: 03 09 2021
accepted: 08 09 2021
pubmed: 18 9 2021
medline: 21 10 2021
entrez: 17 9 2021
Statut: ppublish

Résumé

Water purification from per- and poly-fluoroalkyl substances (PFASs), as a group of persistent and mobile fluoro-organic contaminants, is receiving increasing attention worldwide due to the ubiquitous presence of these highly toxic compounds. To reduce the risk of exposure of human life to PFASs and their dispersion in the environment, various techniques, primarily based on membrane technologies, have been rapidly developed. Here we critically review and analyze the current state-of-the-art of membrane-based techniques for PFASs removal, including direct membrane filtrations, adsorption-based membranes, and hybrid membrane processes. Membranes performance, treatment efficiencies, characteristic parameters and mechanisms for PFASs removal are discussed in detail. We highlight and discuss advantages and limitations, as well as challenges and prospects of individual membrane-based PFASs treatments, pointing towards the practical and sustainable application of these technologies.

Identifiants

pubmed: 34534787
pii: S0160-4120(21)00501-8
doi: 10.1016/j.envint.2021.106876
pii:
doi:

Substances chimiques

Fluorocarbons 0
Water Pollutants, Chemical 0
Water 059QF0KO0R

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106876

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Tonghui Jin (T)

ETH Zurich, Department of Health Sciences and Technology, 8092 Zurich, Switzerland.

Mohammad Peydayesh (M)

ETH Zurich, Department of Health Sciences and Technology, 8092 Zurich, Switzerland.

Raffaele Mezzenga (R)

ETH Zurich, Department of Health Sciences and Technology, 8092 Zurich, Switzerland; ETH Zurich, Department of Materials, Wolfgang-Pauli-Strasse 10, 8093 Zurich, Switzerland. Electronic address: raffaele.mezzenga@hest.ethz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH